Skip to main content Skip to navigation

[University home]

School of Medicine

Dr Bo Fu 

Lecturer in Biostatistics

Health Methodology Research Group,
School of Community Based Medicine,
University of Manchester,
Office 1.304, Jean McFarlane Building, University Place,
Oxford Road, Manchester, M13 9PL, UK.
Tel: +44(0)161 2755054

&

ARC Epidemiology Unit,
University of Manchester,
Oxford Road, Manchester, M13 9PT, UK.
 

 

Role

Bo Fu is a Lecturer in Biostatistics at Health Methodology Research Group of School of Community-Based Medicine and also affiliated to Arthritis Research UK Epidemiology Unit of School of Translational Medicine.

 

Memberships of Committees and Professional Bodies

  • Fellow, Royal Statistical Society (Since 2003)
  • Member, International Chinese Statistical Society (Since 2006)
  • Senior Member, Wolfson College, University of Cambridge (2003-2006)
  • Associate Member, St Edmund’s College, University of Cambridge (2003-2006)

Research

Major clinical projects involved in ARC Epidemiology Unit:

 

Methodological Knowledge

Statistics: longitudinal data, survival analysis, selection bias, causal inference, dynamic panel data, median and quantile regression, time series, latent variable modelling, high-dimensional correlated data, statistical diagnostics and influence analysis.

 

Epidemiology:  observational study, case-control study, cohort study, bias, confounding, causal effect, propensity score weighting, marginal structural model, natural history study, genetic association study 

 

Teaching

  • MSc Biostatistics
  • Statistical advisor for 4th year medical students' projects
  • Statistical advisor for postgraduate research students
 

Biography

Bo Fu got his BSc in Mathematics and MSc in Statistics both from Southeast University, Nanjing, China and his PhD in Statistics from University of Hong Kong in 2003. He then worked in MRC Biostatistics Unit, Cambridge as MRC Career Development Research Fellow in 2003-2006. Before joining the University of Manchester in March 2007, he worked in Nanyang Technological University, Singapore as Assistant Professor in Statistics.

 

Qualifications


 

Collaborators and affiliated staff


 

Publications

2012

  • Dai H, Fu B. (2012). A polar coordinate transformation for estimating bivariate survival functions with randomly censored and truncated data. Journal of Statistical Planning and Inference, 142, 248-262. eScholarID:127885 | DOI:10.1016/j.jspi.2011.07.013
  • Fu B, Wang W, Shi X. (2012). A risk analysis based on a two-stage delayed diagnosis regression model with application to chronic disease progression. European Journal of Operational Research, 218(3), 847-855. eScholarID:138917 | DOI:10.1016/j.ejor.2011.12.013

2011

  • Barrow H, Guo X, Wandall H, Pedersen J, Fu B, Zhao Q, Chen C, Rhodes J, Yu L. (2011). Serum galectin-2, -4 and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clinical Cancer Research, 17(22), 7035-7046. eScholarID:130471 | DOI:10.1158/1078-0432.CCR-11-1462
  • Fu B, Lunt M, Galloway J, Dixon W, Hyrich K, Symmons D. (In-press). A threshold hazard model for estimating serious infection risk following anti-TNF therapy in rheumatoid arthritis patients. Journal of Biopharmaceutical Statistics, eScholarID:129079
  • Fu B, Wang W, Shi X. (2011). Impact of delayed diagnosis time in estimating progression rates to hepatitis C virus (HCV)-related cirrhosis and death. Statistical Methods in Medical Research DOI: 10.1177/0962280211424667, eScholarID:129761 | DOI:10.1177/0962280211424667
  • Galloway J, Hyrich K, Mercer L, Dixon W, Fu B, Ustianowski A, Watson K, Lunt M, Symmons D. (2011). Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first six months of treatment: updated results from the BSR Biologics Register (BSRBR) with special emphasis on risks in the elderly. Rheumatology, 50(1), 124-131. eScholarID:82635 | DOI:10.1093/rheumatology/keq242

2010

  • Farragher T, Lunt M, Fu B, Bunn D, Symmons D. (2010). Early treatment with and time on first Disease Modifying Anti-Rheumatic Drug predicts long-term function in patients with inflammatory polyarthritis. Annals of Rheumatic Diseases, 69(4), 7. eScholarID:73546 | DOI:10.1136/ard.2009.108639
  • Fu B. (2010). Latent mixture quantile regression for longitudinal data. eScholarID:108261

2009

  • Fu B., Tom B., Bird SM. (2009). Reweighted estimation of progression to cirrhosis when analysis is based on Hepatitis C diagnosed patients referred to liver clinics. Statistical Methods in Medical Research, 18, 303-320. eScholarID:1d20363 | DOI:10.1177/0962280208094688

2007

  • Fu B, Tom B, Delahooke T, Alexander GJM, Bird S M. (2007). Event-biased referral can distort estimation of hepatitis C virus progression rate to cirrhosis, and of prognostic influences. Journal of Clinical Epidemiology, 60, 1140-1148. eScholarID:1d15598

2004

  • S Bond, Fu B. (2004). Review of "Essential Medical Statistics" by Kirkwood BR and Sternc JAC. International Journal of Epidemiology, 33, 1418-1419. eScholarID:1d32851

2003

  • Fu B, Fung W K, He X. (2003). Robust analysis of longitudinal data. Journal of the Japanese Society of Computational Statistics, 15, 81-87. eScholarID:1d15597
  • He X, Fu B, Fung W. (2003). Median regression for longitudinal data. Statistics in Medicine, 22( 23), 3655-3669. eScholarID:1d15594
  • Lee A, Fung W, Fu B. (2003). Analyzing hospital length of stay: mean or median regression? Med Care, 41( 5), 681-686. eScholarID:1d15595 | DOI:10.1097/01.MLR.0000062550.23101.6F

2002

  • Fu B, Li W K, FungW K. (2002). Testing model adequacy for dynamic panel data with intercorrelation. Biometrika, 89, 591-602. eScholarID:1d15596

Top of page

| Skip to main content | Skip to navigation | Skip to Search |